College of Sciences

Department of Mathematics

Name: Elissa Schwartz
Field of Study: Infectious Disease Dynamics
Title: Assistant Professor
Degrees: Ph.D., Biomedical Sciences, Mount Sinai-NYU
Homepage: Click
Office: Eastlick 289/Neill 309
Email: ejs at wsu dot edu
Phone: 509-335-5631/509-335-3142
Fax: 509-335-3184
Mailing Address: Washington State University
School of Biological Sciences
PO Box 644236
Pullman, WA 99164-4236

Research Interests

My research combines experimental and theoretical techniques to investigate mechanisms in virology, immunology, and infectious disease epidemiology.  Mathematical studies used in conjunction with data can suggest unforeseen biological mechanisms, determine biologically important rate parameters and evaluate pathogenic mechanisms that are difficult to test directly.  A systems biology approach that couples mathematics with experiments has the potential to advance our basic understanding of pathogenic mechanisms and to lead to new therapeutic strategies.

Currently my research group is examining the control of lentiviral infection, including human immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV). We use mathematical and computational models of viral dynamics with clinical and experimental data to elucidate the determinants of virus control and escape. Our long-term goal is to uncover fundamental viral or immune mechanisms and to develop effective vaccine strategies.

Other current projects investigate the epidemic spread of influenza infection as well as viral evolution in bacteriophage populations.

Representative Publications


Schwartz EJ, Morgan M, Lapin S. Pandemic 2009 H1N1 influenza in two settings in a small community: the workplace and the university campus.  Epidemiology & Infection, In Press.

Vaidya NK, Morgan M, Jones T, Miller L, Lapin S, Schwartz EJ. Modelling the epidemic spread of an H1N1 influenza outbreak in a rural university town. Epidemiology & Infection, In Press.

Schwartz EJ, de Pillis LG. Computational model of HIV-1 escape from the cytotoxic T lymphocyte response.  Canadian Applied Mathematics Quarterly, In Press.

Schwartz EJ, Smith? RJ. (2014) Identifying the conditions under which antibodies protect against infection by equine Infectious anemia virus.  Vaccines 2:397-421.

Ciupe SM, Schwartz EJ. (2014) Understanding virus-host dynamics following EIAV infection in SCID horses.  J. Theoretical Biology 343:1-8.

Miller L, Jones T, Morgan M, Lapin S, Schwartz EJ. (2013) Individual-based computational model used to explain pandemic 2009 H1N1 in rural campus community. J. Biological Systems 21(4):134005.

Schwartz EJ, Pawelek KA, Harrington K, Cangelosi R, Madrid S. (2013) Immune control of equine infectious anemia virus infection by CTLs and antibodies. Applied Mathematics 4:171-177.

Mushayabasa S, Bhunu CP, Schwartz EJ, Magombedze G, Tchuenche JM. (2011) Socio-economic status and HIV/AIDS dynamics: a modeling approach. World Journal of Modeling and Simulation 7(4):243-57.

Snedecor SJ, Strutton D, Ciuryla V, Schwartz EJ, Botteman M.  (2009) Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations.  Vaccine  27(34):4694-703.

Anton PA, Ibarrondo FJ, BoscardinWJ, Zhou Y, Schwartz EJ, Ng HL, Hausner MA, Shih R, Elliott J, Hultin PM, Hultin LE, Price C, Fuerst M, Adler A, Wong JT, Yang OO, and Jamieson BD.  (2008) Differential Immunogenicity of Vaccinia and HIV-1 Components of a Recombinant Vaccine in Mucosal and Blood Compartments.  Vaccine  26:4617-4623.

Smith RJ, Schwartz EJ. (2008) Predicting the potential impact of a cytotoxic T lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be? Math Biosci 212:180-187.

Schwartz EJ, Bodine EN, Blower S. (2007) Effectiveness and Efficiency of Imperfect Therapeutic HSV-2 Vaccines.  Human Vaccines 3(6):231-238.

Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. (2005) Highly Active Antiretroviral Therapy and the Epidemic of HIV+ End-Stage Renal Disease. J Am Soc Nephrol 16(8):2412-20.

Schwartz EJ, Blower S. (2005) Predicting the Potential Individual- and Population-Level Effects of Imperfect Herpes Simplex Virus Type 2 Vaccines. J Infect Dis 191(10):1734-46.

Schwartz EJ, Fierer DS, Neumann AU, Keller MJ, Parkas V, Klotman ME, Winston JA, Klotman PE.  (2002) HIV-1 Dynamics in Hemodialysis Patients.  AIDS 16(9):1301-1303.

Schwartz EJ, Neumann AU, Teixeira AV, Bruggeman LA, Rappaport J, Perelson AS, Klotman PE.  (2002) Effect of Target Cell Availability on HIV-1 Production in Vitro.  AIDS 16(3):341-345.

Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, Reiser J, Mundel P, Klotman PE.  (2001) HIV-1 Induces Loss of Contact Inhibition in Podocytes.  J Am Soc Nephrol  12(8):1677-84.

Department of Mathematics, PO Box 643113, Neill Hall 103, Washington State University, Pullman WA 99164-3113, 509-335-3926, Contact Us